Study guide

10.2 Cardiac Stress Protocols & Vascular Anatomy

ARRT Nuclear Medicine Technology Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Patient Assessment, Care & Emergency Procedures

1.1 Patient Assessment, Medical History & Communication 1.2 Venipuncture, Vascular Access & Emergency Response

2 Chapter 2: Ethical, Legal & Professional Standards

2.1 ARRT Code of Ethics & Patient Rights 2.2 Patient Care in Special Populations & Infection Control

3 Chapter 3: Radiation Physics & Biological Effects

3.1 Atomic Structure, Nuclear Decay & Radiation Interactions 3.2 Biological Effects of Radiation & Radiobiology Principles

4 Chapter 4: Radiation Protection, ALARA & NRC Regulations

4.1 Radiation Protection Principles & ALARA Implementation 4.2 NRC Regulations, Occupational Dose Limits & Area Monitoring 4.3 Radioactive Spills, Contamination Control & Medical Events

5 Chapter 5: Gamma Camera Instrumentation & Physics

5.1 Gamma Camera Components & Signal Processing 5.2 Collimation Principles & Types 5.3 Quality Control of Gamma Cameras

6 Chapter 6: Advanced Imaging Modalities: SPECT, PET/CT & QC

6.1 SPECT Instrumentation, Reconstruction & Quality Control 6.2 PET/CT Instrumentation, Coincidence Detection & Crystals 6.3 PET/CT Quality Control, Attenuation Correction & PACS

7 Chapter 7: Radionuclide Production & Generator Systems

7.1 Radionuclide Production Methods 7.2 Mo-99/Tc-99m Generator Operations & Elution 7.3 Generator Quality Control & Breakthrough Testing

8 Chapter 8: Radiopharmaceutical Preparation, QC & Administration

8.1 Radiopharmaceutical Preparation & Chemistry 8.2 Radiochemical Purity & Dose Calibrator Quality Control 8.3 Dose Calculations, Unit Dose Dispensing & Waste Management

9 Chapter 9: Endocrine, Central Nervous System & Gastrointestinal Imaging

9.1 Thyroid & Parathyroid Imaging & Uptake 9.2 Central Nervous System Imaging 9.3 Gastrointestinal & Hepatobiliary Imaging

10 Chapter 10: Cardiovascular Imaging Procedures

10.1 Myocardial Perfusion SPECT Imaging 10.2 Cardiac Stress Protocols & Vascular Anatomy 10.3 Ventricular Function & MUGA Scans 10.4 Myocardial Viability Imaging 10.5 Cardiac Amyloid Imaging (Tc-99m PYP)

11 Chapter 11: Pulmonary, Skeletal & Renal Imaging Procedures

11.1 Pulmonary Ventilation & Perfusion (V/Q) Imaging 11.2 Skeletal System Imaging & 3-Phase Bone Scans 11.3 Renal & Genitourinary Imaging

12 Chapter 12: Tumor, Infection, Hematology & Radiopharmaceutical Therapy

12.1 Oncology PET/CT Imaging with F-18 FDG 12.2 Infection & Tumor Imaging with Special Radiopharmaceuticals 12.3 Therapeutic Radiopharmaceuticals & Radiation Safety Precautions 12.4 Lymphoscintigraphy & Sentinel Lymph Node Mapping

10.2 Cardiac Stress Protocols & Vascular Anatomy

Key Takeaways Explain This Topic AI

Treadmill exercise stress requires achieving a Target Heart Rate of 85% MPHR = (220-age)*0.85.

Pharmacologic stress agents include adenosine/regadenoson/dipyridamole (vasodilators) and dobutamine (inotropic/chronotropic).

Asthma, severe bronchospasm, and recent caffeine intake are major contraindications for vasodilator stress agents.

Aminophylline is the reversal agent for adenosine receptor agonists.

The LAD supplies the anterior/septal walls, the RCA supplies the inferior wall, and the LCX supplies the lateral wall.

Last updated: July 2026

10.2 Cardiac Stress Protocols & Vascular Anatomy

Quick Answer: Cardiac stress testing induces hyperemia to uncover flow-limiting coronary artery stenoses. Physical exercise stress targets ≥ 85 % \ge 85\% ≥ 85% Maximum Predicted Heart Rate (MPHR). Pharmacologic stress utilizes coronary vasodilators (regadenoson, adenosine, dipyridamole) or inotropic/chronotropic stimulation (dobutamine). Knowledge of caffeine contraindications, aminophylline reversal, and 17-segment coronary vascular territories (LAD, RCA, LCX) is essential for board mastery.

Under resting conditions, baseline myocardial blood flow remains normal even in coronary arteries with up to 70 − 80 % 70-80\% 70 − 80% luminal diameter narrowing, owing to compensatory autoregulatory vasodilation of downstream resistance arterioles. Cardiac stress testing exhausts this autoregulatory reserve, creating a flow discrepancy between normal myocardium (where blood flow increases 3- to 5-fold) and ischemic myocardium (where flow fails to increase proportionally).

Exercise Stress Testing Protocols

Symptom-limited treadmill exercise is the physiological gold standard for patients capable of exertion. It provides incremental diagnostic data including functional exercise capacity (in METs), blood pressure kinetics, heart rate recovery, and exercise-induced ST-segment shifts.

The Standard Bruce Protocol

Increases treadmill speed and elevation gradient every 3 minutes:

  • Stage 1: 1.7 mph 1.7\ \text{mph} 1.7 mph at 10 % 10\% 10% grade ( 4.8 METs 4.8\ \text{METs} 4.8 METs )
  • Stage 2: 2.5 mph 2.5\ \text{mph} 2.5 mph at 12 % 12\% 12% grade ( 7.0 METs 7.0\ \text{METs} 7.0 METs )
  • Stage 3: 3.4 mph 3.4\ \text{mph} 3.4 mph at 14 % 14\% 14% grade ( 10.1 METs 10.1\ \text{METs} 10.1 METs )
  • Target Heart Rate (THR) & Double Product

Maximum Predicted Heart Rate (MPHR): MPHR = 220 − Patient Age \text{MPHR} = 220 - \text{Patient Age} MPHR = 220 − Patient Age

Diagnostic Target Heart Rate (THR): THR = 0.85 × MPHR \text{THR} = 0.85 \times \text{MPHR} THR = 0.85 × MPHR

Double Product (Rate-Pressure Product): RPP = Peak Heart Rate × Peak Systolic BP \text{RPP} = \text{Peak Heart Rate} \times \text{Peak Systolic BP} RPP = Peak Heart Rate × Peak Systolic BP . A diagnostic stress test requires RPP > 25 , 000 bpm ⋅ mmHg \text{RPP} > 25,000\ \text{bpm} \cdot \text{mmHg} RPP > 25 , 000 bpm ⋅ mmHg .

Radiopharmaceutical Injection Timing: The radiotracer (Tc-99m sestamibi/tetrofosmin) is injected as a rapid IV bolus when the patient achieves or exceeds 85 % MPHR 85\%\ \text{MPHR} 85% MPHR . The patient must continue exercising for an additional 1.0 to 2.0 minutes post-injection to ensure tracer extraction occurs during maximal hyperemic blood flow.

Absolute Termination Criteria: Drop in systolic BP > 10 mmHg >10\ \text{mmHg} > 10 mmHg with evidence of ischemia, ST-segment elevation > 1.0 mm >1.0\ \text{mm} > 1.0 mm , sustained ventricular tachycardia, central chest pain with ischemic ECG changes, severe ataxia, or patient request to stop.

Pharmacologic Stress Testing

For patients unable to perform adequate treadmill exercise (due to arthritis, peripheral vascular disease, amputation, stroke, or concurrent beta-blocker therapy), pharmacologic agents simulate stress.

1. Coronary Vasodilators (Adenosine Receptor Agonists)

Vasodilators induce direct hyperemic flow in normal coronary arteries via A 2 A \text{A}_{2\text{A}} A 2 A ​ adenosine receptor stimulation. Diseased vessels already at maximum baseline vasodilation cannot increase flow, causing relative regional hypoperfusion.

Regadenoson (Lexiscan): Selective A 2 A \text{A}_{2\text{A}} A 2 A ​ receptor agonist. Administered as a single pre-filled IV bolus ( 0.4 mg / 5 mL 0.4\ \text{mg} / 5\ \text{mL} 0.4 mg /5 mL ) over 10 seconds, followed by a 5 mL 5\ \text{mL} 5 mL saline flush, with radiotracer injected 20 seconds post-flush. Rapid administration, no weight-based calculation required, minimal A 1 / A 2 B \text{A}_1 / \text{A}_{2\text{B}} A 1 ​ / A 2 B ​ side effects.

Adenosine (Adenoscan): Non-selective agonist ( A 1 , A 2 A , A 2 B , A 3 \text{A}_1, \text{A}_{2\text{A}}, \text{A}_{2\text{B}}, \text{A}_3 A 1 ​ , A 2 A ​ , A 2 B ​ , A 3 ​ ). Continuous IV infusion at 140 μ g/kg/min 140\ \mu\text{g/kg/min} 140 μ g/kg/min for 6 minutes. Radiotracer injected at the 3-minute mark. Extremely short half-life ( < 10 seconds <10\ \text{seconds} < 10 seconds ).

Dipyridamole (Persantine): Indirect vasodilator. Inhibits nucleoside transport, preventing cellular reuptake and degradation of endogenous adenosine. Infused at 0.56 mg/kg 0.56\ \text{mg/kg} 0.56 mg/kg IV over 4 minutes. Radiotracer injected 3-5 minutes post-infusion.

Absolute Contraindications for Vasodilators

Active Asthma or Severe Reactive Airway Disease / COPD: Stimulation of A 2 B \text{A}_{2\text{B}} A 2 B ​ and A 3 \text{A}_3 A 3 ​ receptors triggers severe bronchospasm.

2nd or 3rd-Degree AV Block: Without a functioning cardiac pacemaker ( A 1 \text{A}_1 A 1 ​ receptor activation slows AV node conduction).

Recent Caffeine / Methylxanthine Ingestion: Caffeine, theophylline, and aminophylline are competitive antagonists at adenosine receptors. Consuming caffeine or chocolate within 12 to 24 hours prior to testing blunts vasodilation, producing false-negative non-diagnostic scans.

Low Blood Pressure: Systolic BP < 90 mmHg <90\ \text{mmHg} < 90 mmHg .

Reversal Agent for Vasodilators

Aminophylline ( 100 − 250 mg 100-250\ \text{mg} 100 − 250 mg slow IV over 60 seconds) is a direct competitive antagonist that rapidly reverses severe adenosine-induced bronchospasm, AV block, persistent hypotension, or chest pain.

2. Inotropic & Chronotropic Agents (Dobutamine)

Used for patients who cannot exercise AND have contraindications to vasodilators (active asthma or recent caffeine consumption).

Mechanism: Synthetic catecholamine β 1 \beta_1 β 1 ​ -adrenergic receptor agonist. Increases heart rate, myocardial contractility, and systolic blood pressure, directly escalating myocardial oxygen demand.

Protocol: Incremental IV infusion starting at 10 μ g/kg/min 10\ \mu\text{g/kg/min} 10 μ g/kg/min , stepping to 20 , 30 , and 40 μ g/kg/min 20, 30,\ \text{and}\ 40\ \mu\text{g/kg/min} 20 , 30 , and 40 μ g/kg/min in 3-minute stages. If target heart rate is not achieved at 40 μ g/kg/min 40\ \mu\text{g/kg/min} 40 μ g/kg/min , Atropine ( 0.25 − 1.0 mg 0.25-1.0\ \text{mg} 0.25 − 1.0 mg IV) is added to block parasympathetic tone.

Contraindications: Severe ventricular arrhythmias, recent acute MI ( < 7 days <7\ \text{days} < 7 days ), unstable angina, severe aortic stenosis, hypertrophic obstructive cardiomyopathy, uncontrolled hypertension ( > 220 / 120 mmHg >220/120\ \text{mmHg} > 220/120 mmHg ).

Reversal Agent: Short-acting IV beta-blockers such as Esmolol ( 0.5 mg/kg 0.5\ \text{mg/kg} 0.5 mg/kg ) or Metoprolol ( 5 mg 5\ \text{mg} 5 mg IV).

Pharmacologic Agent Class & Mechanism Primary Dose / Protocol Major Contraindications Specific Reversal Agent

Regadenoson Selective A 2 A \text{A}_{2\text{A}} A 2 A ​ Agonist 0.4 mg 0.4\ \text{mg} 0.4 mg IV bolus Caffeine < 12 h <12\text{h} < 12 h , AV block, SBP < 90 <90 < 90 Aminophylline ( 100 − 250 mg 100-250\ \text{mg} 100 − 250 mg IV)

Adenosine Non-selective Adenosine Agonist 140 μ g/kg/min × 6 min 140\ \mu\text{g/kg/min} \times 6\ \text{min} 140 μ g/kg/min × 6 min Active Asthma, Caffeine < 12 h <12\text{h} < 12 h , AV block Stop infusion / Aminophylline

Dipyridamole Adenosine Reuptake Inhibitor 0.56 mg/kg × 4 min 0.56\ \text{mg/kg} \times 4\ \text{min} 0.56 mg/kg × 4 min Active Asthma, Caffeine < 24 h <24\text{h} < 24 h , AV block Aminophylline ( 100 − 250 mg 100-250\ \text{mg} 100 − 250 mg IV)

Dobutamine β 1 \beta_1 β 1 ​ Adrenergic Agonist 10 − 40 μ g/kg/min 10-40\ \mu\text{g/kg/min} 10 − 40 μ g/kg/min + Atropine Severe Arrhythmias, Aortic Stenosis, HTN Metoprolol / Esmolol IV

Coronary Vascular Anatomy & 17-Segment Mapping

Interpreting myocardial perfusion SPECT scans requires mapping observed perfusion defects to specific coronary arterial supply territories across the standard 17-segment left ventricular model.

1. Left Anterior Descending (LAD) Artery

Course along the anterior interventricular sulcus. Gives off Diagonal ( D 1 , D 2 D_1, D_2 D 1 ​ , D 2 ​ ) and Septal perforator branches.

Perfusion Territory: Anterior wall , Anteroseptal wall , Anterior interventricular septum , and Left ventricular apex .

Clinical Significance: High-grade proximal LAD stenoses ("widow-maker") threaten a large percentage of left ventricular mass, presenting as extensive anterior and apical stress defects.

2. Left Circumflex (LCX) Artery

Course along the left atrioventricular groove. Gives off Obtuse Marginal ( O M 1 , O M 2 OM_1, OM_2 O M 1 ​ , O M 2 ​ ) branches.

Perfusion Territory: Lateral wall , Anterolateral wall , and Inferolateral wall .

3. Right Coronary Artery (RCA)

Course along the right atrioventricular groove. Gives off Acute Marginal ( A M AM A M ) branches and, in right-dominant anatomies, the Posterior Descending Artery ( P D A PDA P D A ).

Perfusion Territory: Inferior wall , Inferoseptal wall , Posterior septum , and Right Ventricle .

4. Coronary Dominance

Right-Dominant ( 85 % 85\% 85% of population): P D A PDA P D A arises from the RCA.

Left-Dominant ( 10 % 10\% 10% of population): P D A PDA P D A arises from the LCX.

Co-Dominant ( 5 % 5\% 5% of population): P D A PDA P D A branches arise from both RCA and LCX.